Cognition Therapeutics
CGTX · NASDAQ
$0.7338+$0.0064 (+0.88%)TodayMarket closed ·
Prev close $0.7274
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 37.6% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.0646 | -$0.04 | +38.1% |
| Q1 FY26 | -$0.0689 | -$0.05 | +27.4% |
| Q4 FY25 | -$0.085 | -$0.048 | +43.5% |
| Q3 FY25 | -$0.102 | -$0.06 | +41.2% |
| Q2 FY25 | -$0.1088 | -$0.11 | −1.1% |
| Q1 FY25 | -$0.1125 | -$0.14 | −24.4% |
| Q4 FY24 | -$0.1448 | -$0.17 | −17.4% |
| Q3 FY24 | -$0.2295 | -$0.25 | −8.9% |
Earnings calls
- CGTX - Earnings call Q4 2025
- CGTX - Earnings call Q4 2024
- Special Call - Cognition Therapeutics, Inc.
- Special Call - Cognition Therapeutics, Inc.
- CGTX - Earnings call Q2 2024
- Special Call - Cognition Therapeutics, Inc.
- Special Call - Cognition Therapeutics, Inc.
- CGTX - Earnings call Q4 2023
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.